相似文献
1
Pathology re-review as an essential component of breast cancer management.
Curr Oncol. 2010 Feb;17(1):2-3. doi: 10.3747/co.v17i1.517.
2
Predictors of re-excision in wire-guided wide local excision for early breast cancer: a Western Australian multi-centre experience.
ANZ J Surg. 2015 Jul-Aug;85(7-8):540-5. doi: 10.1111/ans.13067. Epub 2015 Apr 16.
3
Factors associated with re-excision in patients with early-stage breast cancer treated with breast conservation therapy.
Am Surg. 2010 Mar;76(3):331-4.
4
Impact of routine pathology review on treatment for node-negative breast cancer.
J Clin Oncol. 2012 Jun 20;30(18):2227-31. doi: 10.1200/JCO.2011.38.9247. Epub 2012 May 7.
5
Impact of systematic cavity shave margins in breast-conserving surgery at a large community hospital with a low baseline re-excision rate.
Breast J. 2020 Oct;26(10):1960-1965. doi: 10.1111/tbj.14057. Epub 2020 Oct 19.
6
Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Breast J. 2012 Jul-Aug;18(4):339-44. doi: 10.1111/j.1524-4741.2012.01249.x. Epub 2012 May 23.
7
Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer.
Int J Radiat Oncol Biol Phys. 1986 May;12(5):721-5. doi: 10.1016/0360-3016(86)90028-3.
8
Predictors of Residual Disease After Breast Conservation Surgery.
Ann Surg Oncol. 2018 Jul;25(7):1936-1942. doi: 10.1245/s10434-018-6454-1. Epub 2018 May 10.
9
Resection margins in ultrasound-guided breast-conserving surgery.
Ann Surg Oncol. 2011 Feb;18(2):447-52. doi: 10.1245/s10434-010-1280-0. Epub 2010 Aug 24.
10
Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
Ann Surg Oncol. 2008 Mar;15(3):843-7. doi: 10.1245/s10434-007-9681-4. Epub 2007 Nov 7.
本文引用的文献
1
Inter-institutional pathology consultations for breast cancer: impact on clinical oncology therapy recommendations.
Curr Oncol. 2010 Feb;17(1):25-32. doi: 10.3747/co.v17i1.461.
2
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
3
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
J Clin Oncol. 2007 Jan 1;25(1):118-45. doi: 10.1200/JCO.2006.09.2775. Epub 2006 Dec 11.
4
Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board.
Cancer. 2006 Nov 15;107(10):2346-51. doi: 10.1002/cncr.22266.
5
The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience.
Cancer. 2001 Apr 1;91(7):1231-7. doi: 10.1002/1097-0142(20010401)91:7<1231::aid-cncr1123>3.0.co;2-k.
6
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.
J Clin Oncol. 1999 May;17(5):1474-81. doi: 10.1200/JCO.1999.17.5.1474.
Zotero 插件